IMP761 was well tolerated in healthy volunteers when given at single increasing doses, with no safety concerns, according to ...
When Brenda Snow started experiencing vertigo, vision problems, and other symptoms in the early 1990s, she visited several ...
Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care ...
Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.
On March 17, 2006, Billy Talent drummer Aaron Solowoniuk wrote a letter to fans explaining the meaning behind the song This ...
The UK banned the use of home‑donated plasma in 1998 over fears it could transmit variant Creutzfeldt–Jakob disease (vCJD), ...
A genetic mutation tied to keeping the brain healthy at high altitudes may point to a way to repair nerve damage, experiments in mice show.
Obexelimab marketing applications for the treatment of IgG4-RD expected to be submitted to the FDA in Q2 2026 and the EMA in H2 2026 based on ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis ...
TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...
A newly discovered mechanism that protects nerve cells could have important implications for understanding and treating ...
While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results